GLENMARK PHARMACEUTICALS
Sector : Pharmaceuticals and health care | Largecap | BSE
Here's the live share price of Glenmark Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.
2.79₹ 51.35
As on Nov 20, 2025, 4:01 PM IST
Glenmark Pharmaceuticals Price Performance
Today's LowToday's High
₹1,842.95₹1,893.35
₹1,891.55
52 Weeks' Low52 Weeks' High
₹1,275.50₹2,284.80
₹1,891.55
Open Price
₹1,849.95
Prev. Close
₹1,840.20
Volume
23,863
Over the last 5 years, the share price of Glenmark Pharmaceuticals has gained 31.48% CAGR. Over the past year, the corresponding return has been 29.09%.
Glenmark Pharmaceuticals’s current P/E of 52.86x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Glenmark Pharmaceuticals Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Glenmark Pharmaceuticals | 0.81 | 2.09 | -1.63 | 31.65 | 29.09 | 66.26 | 31.48 |
| Sun Pharmaceutical Industries | 2.42 | 5.29 | 8.76 | 4.13 | 0.01 | 21.02 | 28.73 |
| Divi's Laboratories | -1.86 | -2.06 | 7.69 | 0.24 | 8.22 | 25.56 | 13.26 |
| Torrent Pharmaceuticals | -2.85 | 4.09 | 1.46 | 14.59 | 19.71 | 31.71 | 23.29 |
| Cipla | 0.28 | -6.66 | -1.02 | 5.20 | 4.40 | 11.46 | 15.64 |
| Dr. Reddy's Laboratories | 1.09 | -2.68 | 0.19 | 1.86 | 4.47 | 12.77 | 5.96 |
| Zydus Lifesciences | -1.76 | -7.44 | -5.64 | 5.08 | -1.76 | 32.70 | 16.87 |
| Lupin | -1.08 | 4.42 | 4.66 | 3.36 | -0.61 | 41.23 | 18.26 |
| Mankind Pharma | -0.80 | -8.79 | -10.68 | -12.26 | -12.32 | 16.27 | 9.46 |
| Aurobindo Pharma | -0.04 | 9.85 | 15.52 | 1.40 | -0.97 | 37.60 | 7.71 |
| Alkem Laboratories | -0.72 | 2.26 | 5.29 | 7.99 | 1.39 | 22.59 | 16.23 |
| Abbott India | 0.32 | -0.88 | -9.10 | -3.71 | 9.23 | 14.79 | 14.09 |
| Laurus Labs | -0.51 | 7.74 | 13.27 | 67.19 | 102.84 | 29.68 | 28.54 |
| Biocon | -5.17 | 8.59 | 10.06 | 18.86 | 22.39 | 11.51 | -1.20 |
| GlaxoSmithKline Pharmaceuticals | 0.35 | -8.86 | -10.17 | -10.23 | 5.53 | 24.11 | 10.45 |
| Ipca Laboratories | 10.11 | 12.86 | 4.78 | -1.22 | -8.82 | 18.20 | 6.01 |
| Anthem Biosciences | -7.23 | -10.91 | -22.97 | -11.30 | -11.30 | -3.92 | -2.37 |
| Ajanta Pharma | -1.62 | 2.92 | -6.51 | -3.52 | -15.05 | 26.79 | 19.72 |
| Gland Pharma | -0.40 | -5.46 | -6.39 | 21.63 | 1.74 | 1.98 | -0.01 |
| J B Chemicals & Pharmaceuticals | -4.15 | 3.19 | 0.91 | 2.34 | 1.68 | 18.60 | 30.06 |
Over the last one year, Glenmark Pharmaceuticals has gained 29.09% compared to peers like Sun Pharmaceutical Industries (0.01%), Divi's Laboratories (8.22%), Torrent Pharmaceuticals (19.71%). From a 5 year perspective, Glenmark Pharmaceuticals has outperformed peers relative to Sun Pharmaceutical Industries (28.73%) and Divi's Laboratories (13.26%).
Glenmark Pharmaceuticals Financials
Glenmark Pharmaceuticals Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,865.66 | 1,851.72 |
| 10 | 1,845.15 | 1,852.67 |
| 20 | 1,848.57 | 1,861.96 |
| 50 | 1,941.1 | 1,899.16 |
| 100 | 1,969.66 | 1,878.75 |
| 200 | 1,710.63 | 1,771.75 |
Glenmark Pharmaceuticals Share Holding Pattern
In the latest quarter, Glenmark Pharmaceuticals remained same as its previous close in promoter holding, while DII stake increased to 18.61%, FII holding rose to 20.73%, and public shareholding moved down to 13.97% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Glenmark Pharmaceuticals Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 1,26,36,078 | 2.67 | 2,389.74 | |
| 18,64,031 | 3.78 | 352.53 | |
| 16,62,235 | 1.56 | 314.36 | |
| 13,61,025 | 0.8 | 257.4 | |
| 13,42,939 | 2.81 | 253.98 | |
| 10,48,046 | 0.7 | 198.21 | |
| 9,89,000 | 3.09 | 187.04 | |
| 9,56,043 | 6.41 | 180.81 | |
| 9,52,877 | 1.04 | 180.21 | |
| 8,85,046 | 0.16 | 167.38 |
* Excluding Index & Arbitrage Funds
Glenmark Pharmaceuticals Futures
| Price | (%) As on Invalid Date IST |
| Open Interest | (%) |
| High | |
| Low | |
| Open | |
| Close | |
| Contract Traded | |
| Turnover (in lakhs) |
Glenmark Pharmaceuticals Options
Glenmark Pharmaceuticals Corporate Actions
Date Time | Announcement |
|---|---|
| Nov 19, 2025, 10:47 PM IST | Glenmark Pharma - Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
| Nov 18, 2025, 8:11 PM IST | Glenmark Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Nov 17, 2025, 6:31 PM IST | Glenmark Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
| Nov 14, 2025, 11:49 PM IST | Glenmark Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Nov 14, 2025, 11:42 PM IST | Glenmark Pharma - Announcement under Regulation 30 (LODR)-Investor Presentation |
About Glenmark Pharmaceuticals
Glenmark Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 18/11/1977 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24299MH1977PLC019982 and registration number is 019982. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 9226.41 Cr. and Equity Capital is Rs. 28.22 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressB/2, Mahalaxmi Chambers, Mumbai Maharashtra 400026
- Contact
Management
- Mr. Glenn SaldanhaChairman & Managing Director
- Mrs. Cherylann PintoExecutive Director
- Mr. Anurag MantriExecutive Director & Global CFO
- Mrs. B E SaldanhaNon Executive Director
- Ms. Saira RamasastryInd. Non-Executive Director
- Mrs. Vijayalakshmi IyerInd. Non-Executive Director
- Mr. Pradeep Kumar SinhaInd. Non-Executive Director
- Mr. Dipankar BhattacharjeeInd. Non-Executive Director
FAQs on Glenmark Pharmaceuticals Share Price
What is the share price of Glenmark Pharmaceuticals?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Glenmark Pharmaceuticals is ₹1,891.55 as on Nov 20, 2025.
What kind of stock is Glenmark Pharmaceuticals?
The Glenmark Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Largecap stock on the BSE.
What is the Market Cap of Glenmark Pharmaceuticals?
The market cap of Glenmark Pharmaceuticals is ₹53,379.69 Cr as on Nov 20, 2025.
What are today's High and Low prices of Glenmark Pharmaceuticals?
Today’s highest and lowest price of Glenmark Pharmaceuticals are ₹1,893.35 and ₹1,842.95.
What are the 52 Week High and 52 Week Low of Glenmark Pharmaceuticals?
The 52-week high/low is the highest and lowest price at which Glenmark Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of Glenmark Pharmaceuticals is ₹2,284.80 and 52-week low of Glenmark Pharmaceuticals is ₹1,275.50 as on Nov 20, 2025.
How has the Glenmark Pharmaceuticals performed historically in terms of returns?
The Glenmark Pharmaceuticals has shown returns of 2.79% over the past day, 2.09% for the past month, -1.63% over 3 months, 29.09% over 1 year, 66.26% across 3 years, and 31.48% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Glenmark Pharmaceuticals?
P/E ratio of and PB ratio of Glenmark Pharmaceuticals are 52.86 and 6.03 on Nov 20, 2025. While the company gives a dividend yield of 0.13 per annum.
Glenmark Pharmaceuticals News
✕
Market Pulse